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Abstract  
    Chronic  renal failure is a continuous decreased loss of renal function 
which leads to long term renal treatment including renal replacement 
therapy. One of the renal therapeutic options is renal haemodialysis, which 
acts in removing body’s waste products, including creatinine, urea and 
excess water. The present study was conducted to study the frequency of 
some hematological and chemical parameters among patients with chronic 
kidney disease at Royal Medical City Clinics. Study methodology implied 
withdrawing blood samples from study participants to carry out the 
following hematological and chemical parameters: hemoglobin, hematocrit, 
mcv, bun, creatinine, phosphorous, calcium, albumin, sodium, and 
potassium. Study findings showed that patients were anemic (hemoglobin 
8.99). Chemical parameters indicated that renal dialysis was not able to 
effectively maintain chemical constituents of the body. Taken together, the 
current renal dialysis regimens need to be revised in terms of duration and 
frequency. 
 
Keywords: Chronic kidney disease, renal dialysis, erythropoietin, bun, 
creatinine, albumin   
 
Introduction  
   It is believed that chronic renal failure to be a continuous decreased 
loss of renal function which leads to long term renal treatment including 
renal replacement therapy. One of the renal therapeutic options is renal 
haemodialysis, which acts in removing body’s waste products, including 
creatinine, urea and excess water (Amin et al., 2014).  
    In their study, Levey et al (2007) showed that chronic kidney disease 
(ckd) as one of the major public health problems worldwide. In a previous 
study by Levey et al (2003), it has been estimated that about twenty six 
million adults having non-dialysis dependent kidney disease in  the united 
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states. In another study, it has been estimated that more than 13% of  the us 
population to have chronic renal disease (Coresh et al., 2007). Furthermore, 
the prevalence of ckd is expected to increase wit time worldwide (Bethesda, 
2009).  
   Chronic renal failure is associated with a continuous reduction in 
glomerular filtration rate (gfr) which, in turn, causes the accumulation of 
various chemicals in the blood including urea and creatinine (Amin et al., 
2014).  It has been indicated that  gfr of less than 60 ml/minute/1.73 m2 
gives the indication of ckd (Couchoud et al., 1999).  
    Studies have identified increased blood pressure to be one of the 
main factors causing kidney failure. It is plausible that hypertension induces 
kidney failure through impacting the blood vessels within the kidney which, 
in turn, has effects on the secretion of waste products. It has been observed 
that the waste may be secreted into extra cellular fluid leading to more 
increased blood pressure ending with esrd (Santulli, Trimarco and Iaccarino, 
2013). 
    Haemodialysis is considered as a good therapeutic option in the 
context  of the renal replacement therapies. Body waste product including 
urea, creatinine and free water are removed from the blood in case of 
impaired kidneys. From an economic point of view, dialysis is considered 
cheaper compared with the high cost of renal transplant. So, dialysis has 
superiority over renal transplant particularly, when the possibility of 
rejection is taken into account (Abram and Anju, 2012). The frequency of 
haemodialysis is 2-3 times per week, whereas dialysis time ranged from 2-4 
hours depending on several factors among which are kidney function, 
amount of waste in body, level of salts and body weight. Several 
complications have been associated with haemodialysis such as sleeping 
sickness, exhaustion low blood pressure, chest pain, nausea, leg cramp, 
anemia and headache (Unruh et al., 2011).  
    It has been observed that ckd is associated with anemia since 
erythropoietin production is reduced as a consequence of impaired function 
of kidneys in case of chronic renal failure (Hodges et al., 2007).  
    The effect of haemodialysis on the elimination of excess body waste 
as well as hemoglobin level of patients was investigated. Researchers 
analyzed 70 patients. They found that 53% of patients to have serum urea 
level above 200 mg/dl before dialysis, which reduced to about 100 mg/dl  
after dialysis; serum creatinine was among 57% of patients between 7-12 
mg/dl before dialysis, whereas after dialysis 58% of patients had their 
creatinine levels below 7 mg/dl (Amin et al., 2014). 
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Study objectives  
 To study the frequency of some hematological and chemical 
parameters among patients with chronic kidney disease at royal medical city 
clinics. 
 
Methodology  
Study design and setting 
 This is an experimental cross sectional study. Participants were 
recruited from internal medical clinics who visited renal department for 
dialysis. 
 
Study sample 
 Study sample included 262 patients with chronic kidney disease and 
subjected to renal dialysis. 
 
Blood samples 
 Two blood samples were taken from each patient, one with 
anticoagulant for hematological investigations such as hemoglobin, 
hematocrit, and mcv. The other blood sample was used to investigate 
chemical tests including blood urea nitrogen (bun), creatinine, phosphorous, 
calcium, albumin, sodium and potassium. 
 
Statistical analysis  
 Data was entered into spss version 20 for statistical analysis. Data 
was represented as frequencies and percentages for gender and hematocrit 
level. Other parameters were represented as mean and standard deviation.   
 
Results  
 As shown in table 1, the study included 150 (57.3%) males and 112 
(42.7%) females. 
Table 1: frequency of study participants by gender 
Gender  Frequency  Percentage  
Male  
Female  
150 
112 
57.3 
42.7 
  
Erythropoietin administration according to hematocrit level 
 Erythropoietin was given to patients per week according to following 
criteria: 
 If hematocrit level is > 36%, no erythropoietin is required. If 
hematocrit level is between 33-36 %, 1 injection of erythropoietin is 
required, if hematocrit level is between 32-35%, 2 injections of 
erythropoietin are required, and if hematocrit level is < 32%, 3 injections of 
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erythropoietin are required per week. Accordingly, results showed that about 
18% of patients without need for any injections of erythropoietin, about 15% 
of patients required 1 injection of erythropoietin per week, about 44% of 
patients required 2 erythropoietin injections, and about 10% required 3 
injections of erythropoietin weekly.  
Table 2: the criteria of erythropoietin administration according to hematocrit level 
Hematocrit level Frequency  Percentage  
> 36 
33-36 
32-35 
< 32 
Missing  
47 
38 
114 
26 
37 
17.9 
14.5 
43.5 
9.9 
14.1 
 
Hematological and biochemical findings among study participants 
 The results showed that the mean of hematocrit was 26.15% (+ 
11.73%), hemoglobin 8.99 g/dl (+ 7.83), mcv 90.27 (+ 53.54). The mean 
level of bun was 69.52 (+ 30.89), creatinine 9.35 (+ 3.21), the mean level of 
phosphorous 5.48 (+ 6.51), the mean level of calcium 8.75 (+ 0.98), the 
mean level of albumin 39.13 (+ 7.69), the mean level of sodium 138.85 (+ 
4.28), and the mean level of potassium 4.99 (+ 0.96). 
Table 3: hematological and biochemical findings among study participants  
Lab finding  Mean (m) Standard  deviation (sd) 
Hematocrit  26.15 11.73 
Hemoglobin  8.99 7.83 
Mcv 90.27 53.54 
Bun 69.52 30.89 
Creatinine  9.35 3.21 
Phosphorous  5.48 6.51 
Calcium  8.75 0.98 
Albumin  39.13 7.69 
Sodium  138.85 4.28 
Potassium  4.99 0.96 
 
Discussion  
    The present study showed that males were more likely to be involved 
in chronic kidney disease that require renal dialysis compared with females. 
This finding agreed with other studies that reported similar trends (iseki e al., 
1996, 2008).  
    Erythropoietin administration at different doses was required for 
67.9% of patients.  This finding is in line with the context that chronic 
kidney disease is associated with anemia since erythropoietin production is 
reduced as a consequence of impaired function of kidneys in case of chronic 
renal failure (hodges et al., 2007).   
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 The mean mcv was 90.27 which was less compared with other 
studies in which an mcv > 102 fl was associated with increased mortality 
among patients with esrd (Karthik et al., 2011). 
    Bun mean was high among study participants compared with other 
studies which showed the ability of renal dialysis to reduce urea 
approximately to half (Amin et al., 2014).  
 The mean level of creatinine among study patients was 9.35 mg/dl 
after dialysis. Actually, it is still higher than that compared with other studies 
which pointed to creatinine level of 7 mg/dl after dialysis (Amin et al., 
2014).  
The mean phosphorous level in the present study is 5.48 mg/dl and this was 
higher than that compared with other studies in which the highest 
phosphorous level was 4.2 mg/dl (Levin et al., 2007).  
    The mean calcium level in the present study was 8.75 mg/dl and this 
was lower than that reported in other studies in which calcium was 9.2 mg/dl 
(Levin et al., 2007).  
 Finally, the levels of albumin, sodium and potassium were disturbed 
in patients with chronic kidney disease which agree with other studies (Levin 
et al., 2007; Amin et al., 2014).  
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